Ivar Øye

3.8k total citations · 1 hit paper
61 papers, 3.0k citations indexed

About

Ivar Øye is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Ivar Øye has authored 61 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 13 papers in Physiology. Recurrent topics in Ivar Øye's work include Neuroscience and Neuropharmacology Research (9 papers), Treatment of Major Depression (9 papers) and Anesthesia and Sedative Agents (9 papers). Ivar Øye is often cited by papers focused on Neuroscience and Neuropharmacology Research (9 papers), Treatment of Major Depression (9 papers) and Anesthesia and Sedative Agents (9 papers). Ivar Øye collaborates with scholars based in Norway, Sweden and Czechia. Ivar Øye's co-authors include A Maurset, Earl W. Sutherland, Ole Paulsen, Olav Hustveit, Lasse A. Skoglund, Per Skjelbred, Jan‐Bjørn Osnes, Audun Stubhaug, Per Kristian Eide and Tor Skomedal and has published in prestigious journals such as Nature, The Lancet and Annals of Neurology.

In The Last Decade

Ivar Øye

61 papers receiving 2.8k citations

Hit Papers

The Effect of Epinephrine on Adenosine 3',5'-Phosphate Le... 1965 2026 1985 2005 1965 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ivar Øye Norway 26 927 916 881 853 551 61 3.0k
Tomohiro Yamakura Japan 27 1.3k 1.4× 379 0.4× 613 0.7× 1.7k 2.0× 707 1.3× 62 3.4k
S. H. Ngai United States 28 662 0.7× 256 0.3× 737 0.8× 1.1k 1.3× 625 1.1× 83 2.9k
Barry A. Berkowitz United States 37 1.2k 1.3× 364 0.4× 1.4k 1.6× 1.4k 1.6× 449 0.8× 104 4.1k
Raymond M. Quock United States 29 825 0.9× 386 0.4× 1.1k 1.2× 1.6k 1.8× 305 0.6× 147 2.9k
Richard E. Hartman United States 36 1.2k 1.3× 204 0.2× 798 0.9× 819 1.0× 881 1.6× 84 5.4k
Claes Post Sweden 31 928 1.0× 282 0.3× 1.3k 1.4× 1.1k 1.3× 359 0.7× 88 3.0k
Alex Bekker United States 42 852 0.9× 333 0.4× 1.3k 1.5× 1.2k 1.4× 1.4k 2.5× 131 4.5k
S. Spector United States 32 1.4k 1.5× 311 0.3× 729 0.8× 1.7k 1.9× 121 0.2× 68 3.4k
Florence Noble France 39 2.4k 2.6× 613 0.7× 1.4k 1.6× 3.5k 4.1× 163 0.3× 141 5.4k
Gertrude M. Tyce United States 31 888 1.0× 201 0.2× 1.1k 1.3× 1.2k 1.4× 83 0.2× 149 3.4k

Countries citing papers authored by Ivar Øye

Since Specialization
Citations

This map shows the geographic impact of Ivar Øye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivar Øye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivar Øye more than expected).

Fields of papers citing papers by Ivar Øye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivar Øye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivar Øye. The network helps show where Ivar Øye may publish in the future.

Co-authorship network of co-authors of Ivar Øye

This figure shows the co-authorship network connecting the top 25 collaborators of Ivar Øye. A scholar is included among the top collaborators of Ivar Øye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivar Øye. Ivar Øye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schmidt, Axel, Ivar Øye, & Jonas Åkeson. (2008). Racemic, S(+)‐ and R(−)‐ketamine do not increase elevated intracranial pressure. Acta Anaesthesiologica Scandinavica. 52(8). 1124–1130. 11 indexed citations
2.
Øye, Ivar, et al.. (2001). Interindividual differences in the analgesic response to ketamine in chronic orofacial pain. European Journal of Pain. 5(3). 233–240. 23 indexed citations
3.
Øye, Ivar. (2000). Ketamin – medienes nye motedop?. Tidsskrift for Den Norske Laegeforening. 3 indexed citations
4.
Vollenweider, Franz X., Peter Vontobel, Ivar Øye, Daniel Hell, & Klaus L. Leenders. (2000). Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. Journal of Psychiatric Research. 34(1). 35–43. 167 indexed citations
5.
Kumlien, Eva, Per Hartvig, Sven Valind, et al.. (1999). NMDA‐Receptor Activity Visualized with (S)‐[N‐Methyl‐11C]Ketamine and Positron Emission Tomography in Patients with Medial Temporal Lobe Epilepsy. Epilepsia. 40(1). 30–37. 62 indexed citations
6.
Eide, Per Kristian, Audun Stubhaug, Harald Breivik, & Ivar Øye. (1997). Comments on Cervero and Laird, PAIN, 68 (1996) 13-23. Pain. 72(1). 289–291. 22 indexed citations
7.
Eide, Per Kristian, Audun Stubhaug, Ivar Øye, & Harald Breivik. (1995). Continuous subcutaneous administration of the N -methyl-D-aspartic acid (NMDA) receptor antagonist ketamine in the treatment of post-herpetic neuralgia. Pain. 61(2). 221–228. 202 indexed citations
8.
Hustveit, Olav, A Maurset, & Ivar Øye. (1995). Interaction of the Chiral Forms of Ketamine with Opioid, Phencyclidine, σ and Muscarinic Receptors. Pharmacology & Toxicology. 77(6). 355–359. 188 indexed citations
9.
Hartvig, Per, Johann Valtysson, Karl‐Johan Lindner, et al.. (1995). Central nervous system effects of subdissociative doses of (S)-ketamine are related to plasma and brain concentrations measured with positron emission tomography in healthy volunteers*. Clinical Pharmacology & Therapeutics. 58(2). 165–173. 88 indexed citations
10.
Skjelbred, Per, et al.. (1995). Effect of ketamine, an NMDA receptor inhibitor, in acute and chronic orofacial pain. Pain. 61(2). 215–220. 184 indexed citations
11.
Hartvig, Per, Johann Valtysson, Gunnar Antoni, et al.. (1994). Brain kinetics of (R)- and (S)-[N-methyl-11C]ketamine in the rhesus monkey studied by positron emission tomography (PET). Nuclear Medicine and Biology. 21(7). 927–934. 29 indexed citations
13.
Øye, Ivar, et al.. (1993). Altered Behaviour in the Progeny of Rats Exposed to Ketamine, A N‐methyl‐D‐aspartate Receptor Blocker. Pharmacology & Toxicology. 73(4). 240–242. 3 indexed citations
14.
Hustveit, Olav, J. Setekleiv, & Ivar Øye. (1992). Naloxone Counteracts the Fast Development of Tolerance to Morphine in Guinea‐Pig Ileum. Pharmacology & Toxicology. 71(3). 224–228. 6 indexed citations
15.
Øye, Ivar, Ole Paulsen, & A Maurset. (1992). Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors.. Journal of Pharmacology and Experimental Therapeutics. 260(3). 1209–1213. 348 indexed citations
16.
Maurset, A, et al.. (1990). Evidence of a role for NMDA receptors in pain perception. European Journal of Pharmacology. 187(3). 513–518. 131 indexed citations
17.
Maurset, A, Lasse A. Skoglund, Olav Hustveit, & Ivar Øye. (1989). Comparison of ketamine and pethidine in experimental and postoperative pain. Pain. 36(1). 37–41. 125 indexed citations
18.
Osnes, Jan‐Bjørn & Ivar Øye. (1976). Adenosine 3‘, 5’‐cyclic Monophosphate in Perfused Rat Hearts Exposed to Isoprenaline and Dopamine. Acta Physiologica Scandinavica. 96(1). 100–113. 19 indexed citations
19.
Øye, Ivar. (1967). Glycogen Phosphorylase: A Specific Secondary Target System for Adrenergic Stimulation in the Heart. Acta Physiologica Scandinavica. 69(4). 270–275. 5 indexed citations
20.
Søvik, O, Ivar Øye, & M Rosell-Pérez. (1966). The effect of anoxia, 2,4-dinitrophenol and 2-deoxyglucose on muscle glycogen synthetase. Biochimica et Biophysica Acta (BBA) - General Subjects. 124(1). 26–33. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026